SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+7.28%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$110M
AUM Growth
+$110M
(-13%)
Cap. Flow
-$28M
Cap. Flow
% of AUM
-25.56%
Top 10 Holdings %
Top 10 Hldgs %
87.26%
Holding
31
New
11
Increased
4
Reduced
9
Closed
6
Top Buys
| 1 |
Anika Therapeutics
ANIK
|
$2.65M |
| 2 |
OPTN
OptiNose
OPTN
|
$2.44M |
| 3 |
Galapagos
GLPG
|
$2.26M |
| 4 |
Aclaris Therapeutics
ACRS
|
$2.12M |
| 5 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$2.12M |
Top Sells
| 1 |
ADMA Biologics
ADMA
|
$17.4M |
| 2 |
Evolus
EOLS
|
$11M |
| 3 |
Rigel Pharmaceuticals
RIGL
|
$6.04M |
| 4 |
Nektar Therapeutics
NKTR
|
$3.25M |
| 5 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
CalciMedica
CALC
$43.6M
| – | – |
-522,602
| Closed | -$2.17M |
|
27
IO Biotech
IOBT
$106M
| – | – |
-156,167
| Closed | -$270K |
|
|
28
Nektar Therapeutics
NKTR
$563M
| – | – |
-3,480,409
| Closed | -$3.25M |
|
29
Rezolute
RZLT
$624M
| – | – |
-121,479
| Closed | -$310K |
|
30
SCYNEXIS
SCYX
$34.4M
| – | – |
-95,637
| Closed | -$141K |
|
31
Xeris Biopharma Holdings
XERS
$1.26B
| – | – |
-598,086
| Closed | -$1.32M |
|